Skip to main content

As powerful new opioid nears FDA approval, critics ask if U.S. is stoking its drug crisis

As a new medication intended for quick pain relief nears a U.S. approval decision, critics worry about putting another strong opioid on the market amid a devastating opioid crisis.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.